3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
9
Myelodysplastic Syndromes
5
Leukemia, Myelomonocytic, Chronic
3
Targeted Therapy
1
Neoplasms
1
Myeloproliferative Disorders
1
Myeloid Malignancies
1
Glioma
1
Cholangiocarcinoma
1
Interventions
Temozolomide
6
Radiotherapy
4
Cyclophosphamide
3
TIC10 compound
2
Specimen Handling
2
Irinotecan
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Everolimus
2
Etoposide
2
Diphtheria-Tetanus Vaccine
2
tovorafenib
1
spartalizumab
1
ribociclib
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
lorlatinib
1
larotrectinib
1
gallium maltolate
1
fimepinostat
1
etoposide phosphate
1
dostarlimab
1
dipinacoline glutamate
1
dinutuximab
1
balstilimab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
abemaciclib
1
Vaccines
1
Topotecan
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diffuse Intrinsic Pontine Glioma
×
olutasidenib
×
1 year
×
Clear all
No trials found.